Nonclinical evaluation of vaccines

COMMENTS MUST BE RECEIVED BY 15 FEBRUARY 2012

• Recommendations to Assure the Quality, Safety & Efficacy of Live Attenuated Poliomyelitis Vaccines (oral)
  pdf, 1.42Mb
• Comment Form
  doc, 55kb
• STANDARD OPERATING PROCEDURE: Mutant Analysis by PCR and Restrictin Enzyme Cleavage (MAPREC) for Oral Poliovirus (Sabin) Vaccine Types 1, 2 or 3
  pdf, 1.10Mb
• Comment Form
  doc, 39kb
• WHO PROTOCOL: Neurovirulence Test of Types 1, 2 or 3 Live Poliomyelitis Vaccines (Oral) in Monkeys
  pdf, 340kb
• Comment Form
  doc, 39kb

OUTCOMES OF THE EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION, 18-22 october 2010

• Download
  pdf, 24kb

WHO HPV LabNet - Newsletter No. 8

• Download
  pdf, 849kb

Working Group on the Quality, Safety and Efficacy of Japanese Encephalitis Vaccine (live, attenuated) for human use, Bangkok, Thailand, 21-23 February 2012

WHO Informal Consultation on Recommendations to Assure the Quality, Safety and Efficacy of Poliovirus Vaccine, Oral (OPV), Geneva, Switzerland, 27-29 March 2012

CONTACTS

Quality, Safety and Standards (QSS)
Immunization, Vaccines and Biologicals (IVB)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971